Investor Presentaiton
III Key Investment Highlights
2 Attractive Industry Dynamics (III/III)
A highly defensive sector with significant room for continued growth
Pharma Total Market Share
Public Sector 3%
Market Segmentation | Market Share FY2019
Novartis 8%
Pharco 5%
GSK 5%
Sanofi 5%
Amoun 4%
Eipico 3%
Others 42%
Eva 3%
Pfizer 3%
Hikma 2%
Marcyrl 2%
Manufacturing
FY2018
75 Bn
Others
60%
Multinational
49%
Private Sector
48%
Regulated Price
8%
ISP 20%
Distribution
83 Bn
POS 12%
UCP
26%
Retail
111 Bn
Other 69%
Hospitals
(2.2 k ) &
Tenders
23%
The distribution space is the most consolidated segment, with the 3 largest players processing 68% of the market sales
25%
Industry Regulated Margins
Ezaby 2%
Seif 1%
Roushdy 2%
Misr 1%
*Distributors operate on a fixed margin set out by the Ministry of Health (MOH), and is marked down from the regulated price of the
SKU
*In 2016 the distribution margin increased for the 1st time since the 50's from 7% to 8% on locally manufactured products. Also,
the retailers margin increased from 20% to 25%
Distributors
Retailers
*Distribution Margin worldwide is between 7 - 12%, Egypt is on the lower side.
ibnsinapharma
Source: IMS Health, BMI, WHO
14View entire presentation